Il programma vaccinale antinfluenzale per la stagione 2025-26: una sintesi per il setting pediatrico

The seasonal influenza vaccination campaign is the largest and most complex public health intervention conducted annually by the National Health Service, aimed to reduce individual risk of illness, hospitalization and mortality. It also seeks to minimize transmission risk to high-risk groups, thereby decreasing social costs associated with morbidity and mortality. The Ministry of Health releases an annual circular outlining vaccine compositions based on recommendations from the World Health Organization (WHO). Notably, the upcoming 2025-2026 season will be marked by a shift to trivalent vaccines, omitting the B/Yamagata strain due to its absence since March 2020. The inclusion of children aged 6 months to 6 years in vaccination recommendations reflects a strategic public health initiative to control influenza transmission. Effective communication strategies are essential for improving vaccination adherence across vulnerable populations.